INTRODUCTION
In recent years, several investigators have reported an association between chorioamnionitis and cerebral palsy. 1 ± 3 In an attempt to better our understanding of this relationship, during the Magnesium and Neurologic Endpoints Trial (MagNET), 4 we aseptically cultured the chorioamnion space to find out whether any specific bacteria might be significantly associated with cerebral palsy. Previous observations of possible relationships between specific bacteria found at delivery and cerebral palsy had not reached statistical significance. As it happens, although ours was not the first report of the common prevalence for coagulase negative staphylococci (CONS) in the upper reproductive tract at delivery, 5 ours was the first report of a statistically significant association (adjusted odds ratio [OR] 37.7, 95% confidence interval [CI] 3.0 to +I) between CONS cultured from the chorioamnion and cerebral palsy. We recently published this information in abbreviated form. 6 Of importance, the implications of this finding could be more far reaching than originally reported. CONS have become the most prevalent nosocomial pathogen in many, if not all, neonatal intensive care units (NICU). 7, 8 Thus, if CONS are, in fact, important independent predictors of cerebral palsy, as our original data findings suggest, it is conceivable that infections caused by CONS in the NICU might also be related to cerebral palsy. Indeed, it is even conceivable that CONS transmitted from the mother's birth canal to the skin and mucous membranes of the child at the time of delivery could account for NICU infections in the child eventuating in apparent congenital cerebral palsy. 9 It is the purpose of this study to find out whether the occurrence of culture-proven CONS in the NICU, in addition to CONS in the OBJECTIVE: To find out whether there is an association between cultures positive for coagulase negative staphylococci ( CONS ) taken from babies in the Neonatal Intensive Care Unit ( NICU ) and a subsequent outcome of cerebral palsy.
STUDY DESIGN:
At delivery, we obtained cultures from the chorioamnion space and, when medically indicated, we obtained bacterial cultures from children in the NICU. Surviving neonates underwent final examination for cerebral palsy at age 18 months.
RESULTS:
Of six children in the Magnesium and Neurologic Endpoints Trial who had cerebral palsy, chorioamnion cultures had been obtained for five of six. Four of these five children ( 80% ) had CONS -positive cultures, whereas 26 of 102 ( 25% ) children without cerebral palsy were CONS positive ( p = 0.02 ) . In the NICU, of children with cerebral palsy, the prevalence of cultureproven CONS was 80% ( 4 / 5 ) ; for those without cerebral palsy, the prevalence was 17% ( 15 / 86 ) ( p = 0.01 ) . Using multivariable logistic regression to control for confounding, CONS in the chorioamnion remained significant ( adjusted odds ratio [ OR ] 37.7, 95% confidence interval [ CI ] 3.0 to + I; p = 0.003 ) . However, when controlled for extremely low birth weight, nonvertex presentation, and being on a ventilator !20 days, the
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chorioamnion space, is significantly associated with the outcome of cerebral palsy.
METHODS
The methodology used in MagNET is discussed elsewhere. 4 In brief, the purpose of this randomized controlled trial was to learn whether exposure to antenatal magnesium sulfate (MgSO 4 ) in the mother with preterm labor could prevent neonatal intraventricular hemorrhage or cerebral palsy in her child. In essence, two mutually exclusive trials were running in parallel. In the tocolytic arms, pregnant women in active preterm labor at less than 34 completed weeks of gestation in whom the cervix was dilated less than 4 cm were randomized to either MgSO 4 (4-g bolus followed by an infusion of 2 to 3 g of MgSO 4 per hour) or to``other'' tocolytic chosen by the attending clinician (either ritodrine, terbutaline, indomethacin, or nifedipine). In the doubly blinded preventive arms, pregnant women in active preterm labor at less than 34 completed weeks of gestation, but in whom tocolysis was not appropriate because of advanced cervical dilatation (more than 4 cm), were randomized to either a 4-g intravenous bolus of MgSO 4 only (no additional infusion of MgSO 4 ) or to saline control. Mothers with preeclampsia were excluded from MagNET because the use of MgSO 4 is the standard of care in the United States for prophylaxis in preeclampsia; thus, all mothers receive it, and for that reason, we could not randomize them to other treatments or to saline control.
As part of the study, we obtained information on maternal, neonatal and certain biologic predictors, namely, placental cultures and histopathology, umbilical venous interleukin-6 (IL-6) levels, and maternal and umbilical venous ionized magnesium levels.
Surviving children underwent developmental examinations approximately every 3 months up to age 1-1/2 years. The final neurologic diagnosis was made at the 18-month visit. To find out if specific bacteria were associated with the later outcome of cerebral palsy, cultures of the inner surfaces of the amnion and chorion were done using an aseptic method described by Hillier et al. 10 Culturing occurred in 88% (107/122) of trial neonates for whom the presence or absence of cerebral palsy is known.
Data on neonates were collected by a neonatologist (R. C.) and a physician research associate (J. K.) during hospitalization in the NICU, Special, or General Care Nurseries, long before the outcome of cerebral palsy was determined by a pediatric developmentalist (N. R.) who was blinded to the results of the previously acquired bacterial cultures. Among these neonatal data, we obtained information on bacterial cultures done for medical indication (culture indicated because of the child's clinical condition) during neonatal hospitalization. Because CONS were the only bacteria cultured having any appreciable prevalence, we limited our subsequent analysis to the presence or absence of these microbes. Permission to conduct MagNET was granted by the Institutional Review Board, Biological Sciences Division, University of Chicago.
RESULTS
From October 1995 through January 1997, 194 mothers in preterm labor at less than 34 completed weeks of gestation were screened for participation in MagNET. Of these, we found 157 to be eligible; 149 mothers gave informed consent and were randomized. These 149 mothers gave birth to 165 babies (133 singletons, 16 pairs of twins). At randomization, mothers found to be in preterm labor, as Mittendorf et al.
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determined by their treating clinicians, were similar in maternal age (overall mean, 24.7 years), race (black, 88.3%), gestational length (26.7% of pregnancies were <28 completed weeks at randomization), fetal plurality (twins, 10.7%), and presence of preterm premature rupture of the membranes (PPROM) (67.9%). Of 107 total cultures taken at delivery, 37 (36%) were reported as`n o growth,'' 41 (38%) grew solo or pure cultures of one bacterial species only, and 29 (27%) grew mixed cultures of one or more species. Overall, among all chorioamnion cultures, CONS were the most numerous bacteria found, having a prevalence of 28% (30/ 107). Escherichia coli, with a prevalence of 13% (14/107), were the second most frequently cultured organism (Table 1) . Of the six children in the trial who were found to have cerebral palsy at the 18-month evaluation, bacterial cultures had been obtained at delivery for five of these infants. When comparing the species of bacteria with the outcomes, we found that four of five children (80%) with cerebral palsy who had been cultured were positive for CONS, whereas 26 of 102 children (25%) who did not have cerebral palsy were CONS-positive (two-sided Fisher's exact test, p=0.02). Of interest, among cases of cerebral palsy, CONS were the only organism cultured in pure isolation (n=2), and they were the only bacteria found to have a statistically significant association with cerebral palsy.
Of the 122 children who remained in the study for the final developmental examination at 18 months of age, 91 had been admitted to the NICU after delivery. Three children went to the Special Care Nursery, and the remainder went to the General Care Nursery. In regard to medically indicated NICU cultures, among those children who later developed cerebral palsy, the overall prevalence of culture-proven CONS was 80% (4/5); and, for non± cerebral palsy controls, the prevalence of culture-proven CONS was 17% (15/86) (p=0.01).
Of much anecdotal interest is the finding of CONS in the chorioamnion space of a term, normal birth weight child with cerebral palsy whose mother, when in preterm labor earlier in pregnancy, had been randomized in MagNET. This finding may be important in the context of the fact that the majority of cerebral palsy occurs in normal birth weight, not very low birth weight children, but the etiology for most cases of term cerebral palsy has remained an enigma except for its known, previously nonspecific, association with maternal infection. To determine if potential confounding, such as extremely low birth weight, might account for the association between exposure to CONS and cerebral palsy, we evaluated 15 suspected or known predictors of this outcome (see Table 2 for univariate analyses). Using statistical software that permits exact inference in small, categorical data sets, 11 we estimated multivariable logistic regression models with inclusion of possible confounders. In the multivariable model, when controlling for three variables that were significant by univariate analysis, viz., (a) extremely low birth weight ( <1000 g), (b) nonvertex presentation, and (c) being on a ventilator in the NICU for !20 days (see Table 2 ), the presence of CONS in the chorioamnion space remained highly statistically significant (adjusted OR 37.7, 95% CI 3.0 to +I; p=0.003) ( Table 3 ). The finding in the NICU, however, was a different matter. In bivariate models in which CONS-positive cultures in the NICU were first controlled for birth weight, and then separately for being on a ventilator in the NICU for !20 days, CONS-positive cultures in the NICU became statistically insignificant (p=0.39 and p=0.76, respectively). Also, in contrast to the significant finding for chorioamnion cultures positive for CONS shown above, when simultaneously controlled for birth weight ( <1000 g), nonvertex presentation, and for being on a ventilator !20 days, the association between culture-proven CONS in the NICU and cerebral palsy was insignificant (adjusted OR 3.0, 95% CI 0.2 to +I; p=0.42) ( Table 4) .
DISCUSSION
In these data, although a chorioamnion culture positive for CONS is an independent risk factor for cerebral palsy, medically indicated, culture-proven CONS in the NICU are not. In a multivariable logistic regression, the association between cultureproven CONS in the NICU and cerebral palsy was found to be confounded by extremely low birth weight, a well-known risk factor for cerebral palsy, as well as being on a ventilator for !20 days. Thus, these data, although limited by small sample size, do not provide support for the hypothesis that NICU CONS, as well as chorioamnion CONS, could be significantly associated with cerebral palsy. Given the ubiquitous presence of CONS in the NICU, especially in light of their emerging resistance to many antibiotics, 12 this information may provide some measure of relief to neonatologists.
Despite the indolent behavior that CONS may exhibit, and previous thought relegating them to the status of bacterial`c ontaminants,'' a substantial volume of literature now exists that has established the importance of their virulence factors. These include, among others, toxic exoproteins, hemolysins, DNAase, slime, and adhesins. 8 Indeed, it may be this combination of indolence coupled with potential or smoldering virulence that could make CONS a possible``neuropathogen.'' It should be kept in mind that the surface area that CONS could occupy, i.e., the chorioamnion space, and from which they could be highly metabolic under proper growth conditions, is very large. Moreover, if CONS, which have been shown to adhere preferentially to fibronectin, 13 inhabit the chorioamnion space and attach to both the inner surface of the chorion and the outer surface of the amnion, tissues known to be rich in fibronectin, 14 instead of merely filling the space between them, the surface area to which these bacteria could become adherent would be even greater. When colonizing this large space, metabolic products or elicited fetal inflammatory cytokines closely associated with the outcome of cerebral palsy 15 ± 17 have direct access to fetal tissues, including the brain, directly through the umbilical vein. The implication of our data analyses may be that the pathophysiology of CONS in the NICU is sufficiently different from that in the chorioamnion, such that their high prevalence in the nursery is not usually causative for congenital cerebral palsy.
In regard to the possible public health significance of our findings, using the epidemiologic concept of population attributable risk percent, 18 given that the point estimate of the relative risk is 37.7 and the prevalence of CONS in the chorioamnion space is 25% (26/ 102) (assuming that the prevalence of chorioamnion CONS among children who do not have cerebral palsy in our study is the same as that in the population at-large), 90% of all cerebral palsy could be attributed to the presence of CONS in the chorioamnion space (population  attributable risk Using a most conservative estimate in which the relative risk for cerebral palsy associated with the presence of CONS in the chorioamnion space is only 3.0 (lower bound of the 95% CI), instead of 37.7, 33% of cerebral palsy could still be attributed to CONS.
In the near future, based on a better understanding of one possibly avoidable mechanism of cerebral palsy Ð the presence of CONS in the chorioamnion Ð it is essential to conduct confirmatory studies. The goal of such, in addition to the confirmation or refutation of this new hypothesis, would be to reevaluate our current management of the mother in preterm labor or in the mother with preterm premature rupture of the membranes in whom antibiotics are used for prophylaxis. 19 It is conceivable that CONS are being preferentially selected for growth in the chorioamnion space because of growth suppression of other microbes sensitive to the antibiotics being employed when CONS are resistant to the same antibiotics. The use of prophylactic ampicillin and erythromycin for mothers with preterm premature rupture of the Another important goal of further studies is to determine the one or more individual species of CONS that may be associated with the outcome of cerebral palsy. More than 30 species of CONS have been identified, although two species, viz., Staphylococcus epidermidis and S. saprophyticus, have most often been shown to cause disease in man. 8 Identifying causative, individual species could possibly lead to preventive measures that would likely pay a higher dividend, as opposed to the common clinical practice of using more and different antibiotics to which bacteria will usually develop tolerance at some point in time. Mother 1: Preterm premature rupture of the membranes 14 days before delivery with several days' exposure to IV clindamycin and erythromycin, as well as gentamicin on day of delivery. Foulsmelling products of conception. Funisitis was not present. Mixed culture of CONS, E. coli, and ureaplasma were obtained from the chorioamnion. Infant went to the General Care Nursery. There were no variables of concern in the pediatric record.
Mother 5: Delivered 67 days after initial tocolysis. Did, however, have premature rupture of the membranes at delivery for which she received IV ampicillin.
Child 6: Diplegia and left hemiplegia, not walking at 24 months of age. Got``other'' drug in the tocolytic trial. Birth weight: 862 g. Gestational age: 27 w 4 d . Cord iMg at delivery: no specimen acquired. IL-6: no specimen. Grade III IVH was present, but no PVL. PDI: <50. Funisitis was present. No culture was taken of the chorioamnion; however, review of umbilical cord microscopy showed bacilli and cocci in the membranes. In the NICU, a CSF culture was positive for CONS on day-of-life 48. Vancomycin was administered.
Mother 6: PPROM on day of delivery, received IV ampicillin.
